Qualitative protein mutation test for the Epidermal Growth Factor Receptor (EGFR) L858R - Vietnam Registration 230000315/PCBB-BYT
Access comprehensive regulatory information for Qualitative protein mutation test for the Epidermal Growth Factor Receptor (EGFR) L858R in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 230000315/PCBB-BYT and manufactured by Ventana Medical Systems, Inc..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
230000315/PCBB-BYT
000.00.04.G18-230726-0008
anti-EGFR L858R (SP125) Rabbit Monoclonal Primary Antibody
06521924001
Technical Details
Anti-EGFR L858R (SP125) Rabbit Monoclonal Primary Antibody (anti-EGFR L858R (SP125)) is an immunostaining reagent that binds to the membrane and/or cytoplasm and can be used to support the determination of the protein variant of the epidermal growth factor receptor, EGFR L858R. This antibody is used to perform immunohistochemical staining on formalin-fixed, paraffin-embedded tissue sections. The test result must be interpreted by a qualified histopathologist in combination with histological examination, relevant clinical information, and appropriate positive control material. This antibody is intended for in vitro diagnostic use (IVD).
Dates and Status
Jul 26, 2023